JPRN-UMIN000009447已完成未知
Clinical prospective study to investigate efficacy of WT1 peptide (PepTivator(R))-pulsed dendritic cell vaccination therapy - Clinical prospective study to investigate efficacy of WT1 peptide (PepTivator(R))-pulsed dendritic cell vaccination therapy
Seta Clinic Group0 个研究点目标入组 5 人开始时间: 2012年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have: (1)Pulmonary fibrosis or interstitial pneumonia, or history or predisposition of them (2)Serious drug allergy (3)Positive for HIV or HTLV-1 (4)Active autoimmune disease (5)Continuous systemic administration of steroids (6)Other cancers (7)Active infections (8)Pregnant or lactating (9)Serious cardiac disease (10)Any reason why, in the opinion of the investigator, the patient should not participate.
研究者
相似试验
招募中
不适用
Clinical prospective study to investigate efficacy and safety of immune-cell therapy for malignant tumorsMalignant tumorJPRN-UMIN000004610Kanazawa university600
已完成
不适用
Clinical prospective study to investigate efficacy of NK cell therapy for malignant tumors.JPRN-UMIN000008046Seta Clinic Group20
已完成
不适用
The prospective study of the clinical efficacy/adverse event of regorafenib in unresectable metastatic and advanced colorectal cancerColorectal cancerJPRN-UMIN000015404Department of Clinical Oncology, Akita University Hospital50
进行中（未招募）
不适用
Clinical trial to investigate clinical efficacy and tolerability of Tretinoin in actinic keratosis - Tretinoin bei AKMedDRA version: 9.1Level: LLTClassification code 10000614Term: Actinic keratosisactinic keratosisEUCTR2007-000093-23-DEAlmirall Hermal GmbH
进行中（未招募）
不适用
Clinical trial to investigate clinical efficacy and tolerability of Verrumal in actinic keratosis (PoC) - Verrumal in AKactinic keratosisEUCTR2006-005432-24-DEHermal Kurt Herrmann GmbH & Co OHG15